Successful vemurafenib salvage treatment in a patient with primary refractory hairy cell leukemia and pulmonary aspergillosis

[1]  R. Kurzrock,et al.  Rapid response to vemurafenib in a heavily pretreated patient with hairy cell leukemia and a BRAF mutation. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  Till Acker,et al.  Continued response off treatment after BRAF inhibition in refractory hairy cell leukemia. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  G. Follows,et al.  Rapid response of biallelic BRAF V600E mutated hairy cell leukaemia to low dose vemurafenib , 2013, British journal of haematology.

[4]  R. Ballotti,et al.  Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a V600E mutation , 2013, Haematologica.

[5]  A. Hauschild,et al.  Atypical melanocytic proliferations and new primary melanomas in patients with advanced melanoma undergoing selective BRAF inhibition. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  C. von Kalle,et al.  BRAF inhibition in refractory hairy-cell leukemia. , 2012, The New England journal of medicine.

[7]  S. Pileri,et al.  BRAF mutations in hairy-cell leukemia. , 2011, The New England journal of medicine.

[8]  C. Robert,et al.  RAF inhibition and induction of cutaneous squamous cell carcinoma , 2011, Current opinion in oncology.

[9]  A. Tefferi,et al.  BRAF mutations in hairy-cell leukemia. , 2011, The New England journal of medicine.